Joshi R K, Nambiar P M
Department of Dermatology, Al-Huwaylat Hospital, Jubail Industrial City, Saudi Arabia.
Int J Dermatol. 1989 Nov;28(9):612-4. doi: 10.1111/j.1365-4362.1989.tb02541.x.
In an uncontrolled study, the effectiveness of rifampicin was assessed in cutaneous leishmaniasis. Twelve of 15 patients (80%) showed good response. The treatment ranged from 2 to 12 weeks. Tolerance of the drug was excellent and apart from red discolouration of the urine, no other side effects were encountered. Rifampicin appears to have a place in the management of cutaneous leishmaniasis.
在一项非对照研究中，评估了利福平治疗皮肤利什曼病的有效性。15名患者中有12名（80%）显示出良好疗效。治疗时间为2至12周。该药物耐受性良好，除尿液变红外，未出现其他副作用。利福平在皮肤利什曼病的治疗中似乎有一席之地。
